Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Gastrointestinal Cancer|Genitourinary Cancer|Gynecologic Cancer|Sarcoma|Unknown Primary Tumors|Head and Neck Cancer|Skin Cancer
Interventions: DRUG: Atezolizumab
Sponsor: British Columbia Cancer Agency
Collaborators: Hoffmann-La Roche